Evaluation of Mental Flexibility Through Language Tests in Adolescents With Frontal Brain Damage and in Healthy Children in Ages 8-17

This study has been completed.
Information provided by (Responsible Party):
Sheba Medical Center
ClinicalTrials.gov Identifier:
First received: September 27, 2012
Last updated: September 28, 2012
Last verified: September 2012
This study aims to shed light on the theoretical concept of mental flexibility and its manifestation in adolescents following frontal lobe damage, and to develop a test battery for young Hebrew speakers.

Persons With Frontal Lobe Damage With no Specific Language Disorder

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional

Further study details as provided by Sheba Medical Center:

Enrollment: 20
Study Start Date: August 2004
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   8 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A group of children ages 8-17 with frontal lobe damage, who are treated at the children rehabilitation center at sheba medical center

Inclusion Criteria:

  • frontal lobe damage
  • at least one year after injury
  • native hebrew speaker

Exclusion Criteria:

  • specific language disorder
  • premorbid learning disability
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01696292

Children Rehabilitation Department Sheba Medical Center
Ramat Gan, Israel
Sponsors and Collaborators
Sheba Medical Center
  More Information

Responsible Party: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT01696292     History of Changes
Other Study ID Numbers: SHEBA-04-3435-JL-CTIL 
Study First Received: September 27, 2012
Last Updated: September 28, 2012
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Language Disorders
Communication Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on May 24, 2016